9
Participants
Start Date
August 31, 2016
Primary Completion Date
March 31, 2017
Study Completion Date
March 31, 2017
AiCure monitoring and intervention
Participants will use the AiCure app to monitor ingestion of all prescribed doses of Zubsolv®. If a participant misses a dose, takes an incorrect dose, or their data are flagged for suspicious activity, they will be contacted by research staff or the AiCure study team through automated SMS text or by phone.
Montefiore Medical Center, New York